Overseas medical treatment is a potential new area for growth, says health insurer NIB.
NIB says growing its Australian residents health insurance is still the top priority, but the company will explore other ways in which to expand.
"We're particularly interested in exploiting some of the big trends within healthcare such as the accelerating growth of cross-international-border medical treatment," NIB chairman Steven Crane said in the company's annual report released on Friday.
NIB wants to use its brand and distribution to take advantage of the burgeoning demand in Australia and Asia for medical travel, including for cosmetic surgery.
Mr Crane said that the Australian market had matured, competition had intensified, and regulatory constraints on pricing made it harder to lift margins.
News that makes sense
Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.
Consequently, NIB had to pursue new sources of earnings.
NIB's annual profit fall by 0.7 per cent to $67.2 million in the 2012/13 financial year.
The company's shares gained two cents to $2.18.
